Christo Kole
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers 5
- CAR-T cell therapy research 3
-
- interferon and immune responses 2
- Immunotherapy and Immune Responses 2
- Hepatology top 10%
-
- Retinal Development and Disorders 3
- Extracellular vesicles in disease 1
- Pluripotent Stem Cells Research 1
-
- Long-Term Effects of COVID-19 2
- Co-authors
- Dimitriοs SchizasNikolaos CharalampakisMichalis V. KaramouzisAmanda PsyrriDimitrios C. ZiogasEvangelos KoustasPanagiota EconomopoulouStylianos Kykalos
- Cited by
- OncologyCancer ResearchImmunology
- Journals
- PLoS ONE (1 paper)Antioxidants and Redox Signaling (1 paper)Investigative Ophthalmology & Visual Science (1 paper)
- Partner nations
- GreeceUnited StatesFrance
In The Last Decade
Christo Kole
16 papers receiving 662 citations
Hit Papers
Peers
Comparison fields: 5 of 77
- Oncology 319
- Cancer Research 112
- Immunology 153
- Hepatology 52
- Developmental Neuroscience 17
Countries citing papers authored by Christo Kole
This map shows the geographic impact of Christo Kole's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christo Kole with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christo Kole more than expected).
Fields of papers citing papers by Christo Kole
This network shows the impact of papers produced by Christo Kole. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christo Kole. The network helps show where Christo Kole may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Christo Kole, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 3 | |
| 3 | 2023 | 14 | |
| 4 | 2023 | 9 | |
| 5 | 2022 | 6 | |
| 6 | 2022 | 22 | |
| 7 | 2021 | 34 | |
| 8 | 2021 | 10 | |
| 9 | 2021 | 16 | |
| 10 | 2020 | 97 | |
| 11 | 2020 | 19 | |
| 12 | 2020 | 6 | |
| 13 | Immunotherapy for pancreatic cancer: A 2020 updatebreakdown → | 2020 | 308 |
| 14 | 2020 | 44 | |
| 15 | 2020 | 29 | |
| 16 | 2016 | 9 | |
| 17 | 2016 | 42 |
About Christo Kole
Christo Kole is a scholar working on Oncology, Developmental Neuroscience and Neurology, having authored 17 papers that have together received 668 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (5 papers), CAR-T cell therapy research (3 papers), Retinal Development and Disorders (3 papers), interferon and immune responses (2 papers), Immunotherapy and Immune Responses (2 papers), Long-Term Effects of COVID-19 (2 papers), Extracellular vesicles in disease (1 paper) and Pluripotent Stem Cells Research (1 paper). The work is most often cited by research in Oncology (319 citations), Cancer Research (112 citations) and Immunology (153 citations). Christo Kole has collaborated with scholars based in Greece, United States and France. Frequent co-authors include Dimitriοs Schizas, Nikolaos Charalampakis, Michalis V. Karamouzis, Amanda Psyrri, Dimitrios C. Ziogas, Evangelos Koustas, Panagiota Economopoulou, Stylianos Kykalos, Michail Vailas and Dimitrios Moris. Their work appears in journals such as PLoS ONE, Antioxidants and Redox Signaling and Investigative Ophthalmology & Visual Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.